HRSV Post-Fusion glycoprotein F0 Specific ELISA Kit (For Vaccine Development)

产品详情

ID	Components	Size
RAS204-C01	Pre-coated Anti-Post-Fusion glycoprotein F0 (RSV) Antibody Microplate	1 plate
RAS204-C02	Post-Fusion glycoprotein F0 (RSV) Standard	20 μg
RAS204-C03	HRP-Anti-RSV-F0 Antibody	20 μg
RAS204-C04	10×Washing Buffer	50 mL
RAS204-C05	2×Dilution Buffer	50 mL
RAS204-C06	Substrate Solution	12 mL
RAS204-C07	Stop Solution	7 mL

产品概述（Product Overview）
Most in vitro RSV neutralizing antibodies in human sera are directed against the prefusion conformation, but due to its instability the prefusion conformation has a propensity to prematurely refold into the stable postfusion conformation, both in solution and on the surface of the virions.
An RSV F protein that has both high expression levels and maintains a stable prefusion conformation would, therefore, be a promising subunit vaccine candidate against RSV.
To facilitate the RSV-related research, drug trials and vaccine development,a rapid and effective assay kit detecting the specific levels of HRSV Post-Fusion glycoprotein F0 is urgently needed to accelerate the development of RSV vaccines.
重构方法（Reconstitution）
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
存储（Storage）
1. Unopened kit should be stored at 2℃-8℃ upon receiving.
2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
质量管理控制体系（QMS）

典型数据-Typical Data
Please refer to DS document for the assay protocol.
For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.

联系我们

项目合作